BRIC Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$5995
Buy Report

Published: September 04, 2025 Report Code: GDME20432CRDB-ST

Select Item

GlobalData’s “BRIC Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the BRIC Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests
ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The BRIC Oncology Market report provides key information and data on –
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
• 2023 company share data for Oncology Market.
• Global corporate-level profiles of key companies operating within the BRIC Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

BRIC Oncology is segmented as follows – _x000D_

• Colorectal Cancer Screening Tests_x000D_

• EGFR Tests_x000D_

• KRAS Tests_x000D_

• HER2 Tests_x000D_

• BRCA Tests_x000D_

• ALK Tests_x000D_

• BRAF Tests_x000D_

• BCR-ABL Tests_x000D_

• PD-L1 Tests

Reasons to Buy

The BRIC Oncology Market report helps you to develop –

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

F. Hoffmann-La Roche Ltd_x000D_
BioGenex Laboratories Inc_x000D_
Agilent Technologies Inc_x000D_
Amoy Diagnostics Co Ltd_x000D_
Abbott Laboratories_x000D_
Danaher Corp_x000D_
Eiken Chemical Co Ltd_x000D_
Hemosure Inc_x000D_
Alfresa Pharma Corp_x000D_
Sentinel CH. SpA

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 7

2 Introduction 10

2.1 What Is This Report About? 10

2.2 Oncology Market Segmentation 10

2.3 Definitions of Markets Covered in the Report 12

3 Oncology Market, BRIC 19

3.1 Oncology Market, BRIC, Revenue ($m), 2018-2033 19

3.2 Oncology Market, BRIC, Revenue ($m), 2018-2033 21

3.3 Oncology Market, BRIC, Volume (Units), 2018-2033 24

3.4 Oncology Market, BRIC, Volume (Units), 2018-2033 26

3.5 Oncology Market, BRIC, Company Share by Revenue ($m), 2024 29

4 Oncology Market, China 31

4.1 Oncology Market, China, Revenue ($m), 2018-2033 31

4.1.1 ALK Tests Market, China, Revenue ($m), by Segment, 2018-2033 34

4.1.2 BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Revenue ($m), by Segment, 2018-2033 36

4.1.3 BRAF Tests Market, China, Revenue ($m), by Segment, 2018-2033 38

4.1.4 BRCA Tests Market, China, Revenue ($m), by Segment, 2018-2033 40

4.1.5 Colorectal Cancer Screening Tests Market, China, Revenue ($m), by Segment, 2018-2033 42

4.1.6 EGFR Tests Market, China, Revenue ($m), by Segment, 2018-2033 44

4.1.7 HER2 Tests Market, China, Revenue ($m), by Segment, 2018-2033 46

4.1.8 KRAS Tests Market, China, Revenue ($m), by Segment, 2018-2033 48

4.2 Oncology Market, China, Volume (Units), 2018-2033 50

4.2.1 ALK Tests Market, China, Volume (Units), by Segment, 2018-2033 53

4.2.2 BCR-ABL Tests Market, China, Volume (Units), by Segment, 2018-2033 55

4.2.3 BRAF Tests Market, China, Volume (Units), by Segment, 2018-2033 57

4.2.4 BRCA Tests Market, China, Volume (Units), by Segment, 2018-2033 59

4.2.5 Colorectal Cancer Screening Tests Market, China, Volume (Units), by Segment, 2018-2033 61

4.2.6 EGFR Tests Market, China, Volume (Units), by Segment, 2018-2033 63

4.2.7 HER2 Tests Market, China, Volume (Units), by Segment, 2018-2033 65

4.2.8 KRAS Tests Market, China, Volume (Units), by Segment, 2018-2033 67

4.3 Oncology Market, China, Average Price ($) , 2018-2033 69

4.4 Oncology Market, China, Company Share by Revenue ($m), 2024 72

5 Oncology Market, Russia 74

5.1 Oncology Market, Russia, Revenue ($m), 2018-2033 74

5.1.1 ALK Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 77

5.1.2 BCR-ABL Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 79

5.1.3 BRAF Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 81

5.1.4 BRCA Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 83

5.1.5 Colorectal Cancer Screening Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 85

5.1.6 EGFR Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 87

5.1.7 HER2 Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 89

5.1.8 KRAS Tests Market, Russia, Revenue ($m), by Segment, 2018-2033 91

5.2 Oncology Market, Russia, Volume (Units), 2018-2033 93

5.2.1 ALK Tests Market, Russia, Volume (Units), by Segment, 2018-2033 96

5.2.2 BCR-ABL Tests Market, Russia, Volume (Units), by Segment, 2018-2033 98

5.2.3 BRAF Tests Market, Russia, Volume (Units), by Segment, 2018-2033 100

5.2.4 BRCA Tests Market, Russia, Volume (Units), by Segment, 2018-2033 102

5.2.5 Colorectal Cancer Screening Tests Market, Russia, Volume (Units), by Segment, 2018-2033 104

5.2.6 EGFR Tests Market, Russia, Volume (Units), by Segment, 2018-2033 106

5.2.7 HER2 Tests Market, Russia, Volume (Units), by Segment, 2018-2033 108

5.2.8 KRAS Tests Market, Russia, Volume (Units), by Segment, 2018-2033 110

5.3 Oncology Market, Russia, Average Price ($) , 2018-2033 112

5.4 Oncology Market, Russia, Company Share by Revenue ($m), 2024 116

6 Oncology Market, India 118

6.1 Oncology Market, India, Revenue ($m), 2018-2033 118

6.1.1 ALK Tests Market, India, Revenue ($m), by Segment, 2018-2033 121

6.1.2 BCR-ABL Tests Market, India, Revenue ($m), by Segment, 2018-2033 123

6.1.3 BRAF Tests Market, India, Revenue ($m), by Segment, 2018-2033 125

6.1.4 BRCA Tests Market, India, Revenue ($m), by Segment, 2018-2033 127

6.1.5 Colorectal Cancer Screening Tests Market, India, Revenue ($m), by Segment, 2018-2033 129

6.1.6 EGFR Tests Market, India, Revenue ($m), by Segment, 2018-2033 131

6.1.7 HER2 Tests Market, India, Revenue ($m), by Segment, 2018-2033 133

6.1.8 KRAS Tests Market, India, Revenue ($m), by Segment, 2018-2033 135

6.2 Oncology Market, India, Volume (Units), 2018-2033 137

6.2.1 ALK Tests Market, India, Volume (Units), by Segment, 2018-2033 140

6.2.2 BCR-ABL Tests Market, India, Volume (Units), by Segment, 2018-2033 142

6.2.3 BRAF Tests Market, India, Volume (Units), by Segment, 2018-2033 144

6.2.4 BRCA Tests Market, India, Volume (Units), by Segment, 2018-2033 146

6.2.5 Colorectal Cancer Screening Tests Market, India, Volume (Units), by Segment, 2018-2033 148

6.2.6 EGFR Tests Market, India, Volume (Units), by Segment, 2018-2033 150

6.2.7 HER2 Tests Market, India, Volume (Units), by Segment, 2018-2033 152

6.2.8 KRAS Tests Market, India, Volume (Units), by Segment, 2018-2033 154

6.3 Oncology Market, India, Average Price ($) , 2018-2033 156

6.4 Oncology Market, India, Company Share by Revenue ($m), 2024 160

7 Oncology Market, Brazil 162

7.1 Oncology Market, Brazil, Revenue ($m), 2018-2033 162

7.1.1 ALK Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 165

7.1.2 BCR-ABL Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 167

7.1.3 BRAF Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 169

7.1.4 BRCA Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 171

7.1.5 Colorectal Cancer Screening Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 173

7.1.6 EGFR Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 175

7.1.7 HER2 Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 177

7.1.8 KRAS Tests Market, Brazil, Revenue ($m), by Segment, 2018-2033 179

7.2 Oncology Market, Brazil, Volume (Units), 2018-2033 181

7.2.1 ALK Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 184

7.2.2 BCR-ABL Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 186

7.2.3 BRAF Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 188

7.2.4 BRCA Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 190

7.2.5 Colorectal Cancer Screening Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 192

7.2.6 EGFR Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 194

7.2.7 HER2 Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 196

7.2.8 KRAS Tests Market, Brazil, Volume (Units), by Segment, 2018-2033 198

7.3 Oncology Market, Brazil, Average Price ($) , 2018-2033 200

7.4 Oncology Market, Brazil, Company Share by Revenue ($m), 2024 205

8 Overview of Key Companies in BRIC Oncology Market 207

8.1 F. Hoffmann-La Roche Ltd 207

8.1.1 Company Overview 207

8.2 BioGenex Laboratories Inc 207

8.2.1 Company Overview 207

8.3 Agilent Technologies Inc 207

8.3.1 Company Overview 207

8.4 Abbott Laboratories 207

8.4.1 Company Overview 207

8.5 Danaher Corp 208

8.5.1 Company Overview 208

8.6 Amoy Diagnostics Co Ltd 208

8.6.1 Company Overview 208

8.7 Eiken Chemical Co Ltd 208

8.7.1 Company Overview 208

8.8 Hemosure Inc 208

8.8.1 Company Overview 208

8.9 Alfresa Pharma Corp 208

8.9.1 Company Overview 208

8.10 Qiagen NV 209

8.10.1 Company Overview 209

8.11 Quidelortho Corp 209

8.11.1 Company Overview 209

8.12 Resonac Corporation 209

8.12.1 Company Overview 209

8.13 HLB PanaGene Co Ltd 209

8.13.1 Company Overview 209

8.14 Medline Industries LP 210

8.14.1 Company Overview 210

8.15 Sekisui Diagnostics LLC 210

8.15.1 Company Overview 210

8.16 ZytoVision GmbH 210

8.16.1 Company Overview 210

8.17 Sysmex Corp 210

8.17.1 Company Overview 210

8.18 Thermo Fisher Scientific Inc 210

8.18.1 Company Overview 210

8.19 MRC-Holland BV 211

8.19.1 Company Overview 211

8.20 Asuragen Inc 211

8.20.1 Company Overview 211

9 Oncology Market Pipeline Products 212

10 Appendix 277

10.1 Research Methodology 278

10.1.1 Coverage 278

10.1.2 Secondary Research 278

10.1.3 Primary Research 278

10.1.4 Market Modeling and Forecasting 279

10.1.5 Company Share Analysis 280

10.1.6 Benchmarking 281

10.2 GlobalData Consulting 282

10.3 Contact Us 282

10.4 Disclaimer 282

 

Table

Table 1: Oncology Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2018-2033 20

Table 2: Oncology Market, BRIC, Revenue ($m), USD Constant, 2018-2033 22

Table 3: Oncology Market, BRIC, Volume (Units), 2018-2033 25

Table 4: Oncology Market, BRIC, Volume (Units), 2018-2033 27

Table 5: Oncology Market, BRIC, Company Share by Revenue ($m), 2024 30

Table 6: Oncology Market, China, Revenue ($m), USD Constant, 2018-2033 32

Table 7: ALK Tests Market, China, Revenue ($m), USD Constant, 2018-2033 35

Table 8: BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Revenue ($m), USD Constant, 2018-2033 37

Table 9: BRAF Tests Market, China, Revenue ($m), USD Constant, 2018-2033 39

Table 10: BRCA Tests Market, China, Revenue ($m), USD Constant, 2018-2033 41

Table 11: Colorectal Cancer Screening Tests Market, China, Revenue ($m), USD Constant, 2018-2033 43

Table 12: EGFR Tests Market, China, Revenue ($m), USD Constant, 2018-2033 45

Table 13: HER2 Tests Market, China, Revenue ($m), USD Constant, 2018-2033 47

Table 14: KRAS Tests Market, China, Revenue ($m), USD Constant, 2018-2033 49

Table 15: Oncology Market, China, Volume (Units), 2018-2033 51

Table 16: ALK Tests Market, China, Volume (Units), 2018-2033 54

Table 17: BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Volume (Units), 2018-2033 56

Table 18: BRAF Tests Market, China, Volume (Units), 2018-2033 58

Table 19: BRCA Tests Market, China, Volume (Units), 2018-2033 60

Table 20: Colorectal Cancer Screening Tests Market, China, Volume (Units), 2018-2033 62

Table 21: EGFR Tests Market, China, Volume (Units), 2018-2033 64

Table 22: HER2 Tests Market, China, Volume (Units), 2018-2033 66

Table 23: KRAS Tests Market, China, Volume (Units), 2018-2033 68

Table 24: Oncology Market, China, Average Price ($), 2018-2033 69

Table 25: Oncology Market, China, Company Share by Revenue ($m), 2024 73

Table 26: Oncology Market, Russia, Revenue ($m), USD Constant, 2018-2033 75

Table 27: ALK Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 78

Table 28: BCR-ABL Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 80

Table 29: BRAF Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 82

Table 30: BRCA Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 84

Table 31: Colorectal Cancer Screening Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 86

Table 32: EGFR Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 88

Table 33: HER2 Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 90

Table 34: KRAS Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 92

Table 35: Oncology Market, Russia, Volume (Units), 2018-2033 94

Table 36: ALK Tests Market, Russia, Volume (Units), 2018-2033 97

Table 37: BCR-ABL Tests Market, Russia, Volume (Units), 2018-2033 99

Table 38: BRAF Tests Market, Russia, Volume (Units), 2018-2033 101

Table 39: BRCA Tests Market, Russia, Volume (Units), 2018-2033 103

Table 40: Colorectal Cancer Screening Tests Market, Russia, Volume (Units), 2018-2033 105

Table 41: EGFR Tests Market, Russia, Volume (Units), 2018-2033 107

Table 42: HER2 Tests Market, Russia, Volume (Units), 2018-2033 109

Table 43: KRAS Tests Market, Russia, Volume (Units), 2018-2033 111

Table 44: Oncology Market, Russia, Average Price ($), 2018-2033 112

Table 45: Oncology Market, Russia, Company Share by Revenue ($m), 2024 117

Table 46: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033 119

Table 47: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033 122

Table 48: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033 124

Table 49: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033 126

Table 50: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033 128

Table 51: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033 130

Table 52: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033 132

Table 53: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033 134

Table 54: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033 136

Table 55: Oncology Market, India, Volume (Units), 2018-2033 138

Table 56: ALK Tests Market, India, Volume (Units), 2018-2033 141

Table 57: BCR-ABL Tests Market, India, Volume (Units), 2018-2033 143

Table 58: BRAF Tests Market, India, Volume (Units), 2018-2033 145

Table 59: BRCA Tests Market, India, Volume (Units), 2018-2033 147

Table 60: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033 149

Table 61: EGFR Tests Market, India, Volume (Units), 2018-2033 151

Table 62: HER2 Tests Market, India, Volume (Units), 2018-2033 153

Table 63: KRAS Tests Market, India, Volume (Units), 2018-2033 155

Table 64: Oncology Market, India, Average Price ($), 2018-2033 156

Table 65: Oncology Market, India, Company Share by Revenue ($m), 2024 161

Table 66: Oncology Market, Brazil, Revenue ($m), USD Constant, 2018-2033 163

Table 67: ALK Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 166

Table 68: BCR-ABL Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 168

Table 69: BRAF Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 170

Table 70: BRCA Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 172

Table 71: Colorectal Cancer Screening Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 174

Table 72: EGFR Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 176

Table 73: HER2 Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 178

Table 74: KRAS Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 180

Table 75: Oncology Market, Brazil, Volume (Units), 2018-2033 182

Table 76: ALK Tests Market, Brazil, Volume (Units), 2018-2033 185

Table 77: BCR-ABL Tests Market, Brazil, Volume (Units), 2018-2033 187

Table 78: BRAF Tests Market, Brazil, Volume (Units), 2018-2033 189

Table 79: BRCA Tests Market, Brazil, Volume (Units), 2018-2033 191

Table 80: Colorectal Cancer Screening Tests Market, Brazil, Volume (Units), 2018-2033 193

Table 81: EGFR Tests Market, Brazil, Volume (Units), 2018-2033 195

Table 82: HER2 Tests Market, Brazil, Volume (Units), 2018-2033 197

Table 83: KRAS Tests Market, Brazil, Volume (Units), 2018-2033 199

Table 84: Oncology Market, Brazil, Average Price ($), 2018-2033 200

Table 85: Oncology Market, Brazil, Company Share by Revenue ($m), 2024 206

Table 86: Oncology Market Pipeline Products 212

Table 87: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 279

Figures

Figure 1: Oncology Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2018-2033 19

Figure 2: Oncology Market, BRIC, Revenue ($m), USD Constant, 2018-2033 21

Figure 3: Oncology Market, BRIC, Volume (Units), 2018-2033 24

Figure 4: Oncology Market, BRIC, Volume (Units), 2018-2033 26

Figure 5: Oncology Market, BRIC, Company Share (%), 2024 29

Figure 6: Oncology Market, China, Revenue ($m), USD Constant, 2018-2033 31

Figure 7: ALK Tests Market, China, Revenue ($m), USD Constant, 2018-2033 34

Figure 8: BCR-ABL Nucleic Acid Amplification Tests (NAATs) Market, China, Revenue ($m), USD Constant, 2018-2033 36

Figure 9: BRAF Tests Market, China, Revenue ($m), USD Constant, 2018-2033 38

Figure 10: BRCA Tests Market, China, Revenue ($m), USD Constant, 2018-2033 40

Figure 11: Colorectal Cancer Screening Tests Market, China, Revenue ($m), USD Constant, 2018-2033 42

Figure 12: EGFR Tests Market, China, Revenue ($m), USD Constant, 2018-2033 44

Figure 13: HER2 Tests Market, China, Revenue ($m), USD Constant, 2018-2033 46

Figure 14: KRAS Tests Market, China, Revenue ($m), USD Constant, 2018-2033 48

Figure 15: Oncology Market, China, Volume (Units), 2018-2033 50

Figure 16: ALK Tests Market, China, Volume (Units), 2018-2033 53

Figure 17: BCR-ABL Tests Market, China, Volume (Units), 2018-2033 55

Figure 18: BRAF Tests Market, China, Volume (Units), 2018-2033 57

Figure 19: BRCA Tests Market, China, Volume (Units), 2018-2033 59

Figure 20: Colorectal Cancer Screening Tests Market, China, Volume (Units), 2018-2033 61

Figure 21: EGFR Tests Market, China, Volume (Units), 2018-2033 63

Figure 22: HER2 Tests Market, China, Volume (Units), 2018-2033 65

Figure 23: KRAS Tests Market, China, Volume (Units), 2018-2033 67

Figure 24: Oncology Market, China, Company Share (%), 2024 72

Figure 25: Oncology Market, Russia, Revenue ($m), USD Constant, 2018-2033 74

Figure 26: ALK Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 77

Figure 27: BCR-ABL Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 79

Figure 28: BRAF Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 81

Figure 29: BRCA Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 83

Figure 30: Colorectal Cancer Screening Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 85

Figure 31: EGFR Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 87

Figure 32: HER2 Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 89

Figure 33: KRAS Tests Market, Russia, Revenue ($m), USD Constant, 2018-2033 91

Figure 34: Oncology Market, Russia, Volume (Units), 2018-2033 93

Figure 35: ALK Tests Market, Russia, Volume (Units), 2018-2033 96

Figure 36: BCR-ABL Tests Market, Russia, Volume (Units), 2018-2033 98

Figure 37: BRAF Tests Market, Russia, Volume (Units), 2018-2033 100

Figure 38: BRCA Tests Market, Russia, Volume (Units), 2018-2033 102

Figure 39: Colorectal Cancer Screening Tests Market, Russia, Volume (Units), 2018-2033 104

Figure 40: EGFR Tests Market, Russia, Volume (Units), 2018-2033 106

Figure 41: HER2 Tests Market, Russia, Volume (Units), 2018-2033 108

Figure 42: KRAS Tests Market, Russia, Volume (Units), 2018-2033 110

Figure 43: Oncology Market, Russia, Company Share (%), 2024 116

Figure 44: Oncology Market, India, Revenue ($m), USD Constant, 2018-2033 118

Figure 45: ALK Tests Market, India, Revenue ($m), USD Constant, 2018-2033 121

Figure 46: BCR-ABL Tests Market, India, Revenue ($m), USD Constant, 2018-2033 123

Figure 47: BRAF Tests Market, India, Revenue ($m), USD Constant, 2018-2033 125

Figure 48: BRCA Tests Market, India, Revenue ($m), USD Constant, 2018-2033 127

Figure 49: Colorectal Cancer Screening Tests Market, India, Revenue ($m), USD Constant, 2018-2033 129

Figure 50: EGFR Tests Market, India, Revenue ($m), USD Constant, 2018-2033 131

Figure 51: HER2 Tests Market, India, Revenue ($m), USD Constant, 2018-2033 133

Figure 52: KRAS Tests Market, India, Revenue ($m), USD Constant, 2018-2033 135

Figure 53: Oncology Market, India, Volume (Units), 2018-2033 137

Figure 54: ALK Tests Market, India, Volume (Units), 2018-2033 140

Figure 55: BCR-ABL Tests Market, India, Volume (Units), 2018-2033 142

Figure 56: BRAF Tests Market, India, Volume (Units), 2018-2033 144

Figure 57: BRCA Tests Market, India, Volume (Units), 2018-2033 146

Figure 58: Colorectal Cancer Screening Tests Market, India, Volume (Units), 2018-2033 148

Figure 59: EGFR Tests Market, India, Volume (Units), 2018-2033 150

Figure 60: HER2 Tests Market, India, Volume (Units), 2018-2033 152

Figure 61: KRAS Tests Market, India, Volume (Units), 2018-2033 154

Figure 62: Oncology Market, India, Company Share (%), 2024 160

Figure 63: Oncology Market, Brazil, Revenue ($m), USD Constant, 2018-2033 162

Figure 64: ALK Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 165

Figure 65: BCR-ABL Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 167

Figure 66: BRAF Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 169

Figure 67: BRCA Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 171

Figure 68: Colorectal Cancer Screening Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 173

Figure 69: EGFR Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 175

Figure 70: HER2 Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 177

Figure 71: KRAS Tests Market, Brazil, Revenue ($m), USD Constant, 2018-2033 179

Figure 72: Oncology Market, Brazil, Volume (Units), 2018-2033 181

Figure 73: ALK Tests Market, Brazil, Volume (Units), 2018-2033 184

Figure 74: BCR-ABL Tests Market, Brazil, Volume (Units), 2018-2033 186

Figure 75: BRAF Tests Market, Brazil, Volume (Units), 2018-2033 188

Figure 76: BRCA Tests Market, Brazil, Volume (Units), 2018-2033 190

Figure 77: Colorectal Cancer Screening Tests Market, Brazil, Volume (Units), 2018-2033 192

Figure 78: EGFR Tests Market, Brazil, Volume (Units), 2018-2033 194

Figure 79: HER2 Tests Market, Brazil, Volume (Units), 2018-2033 196

Figure 80: KRAS Tests Market, Brazil, Volume (Units), 2018-2033 198

Figure 81: Oncology Market, Brazil, Company Share (%), 2024 205

BRIC Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others standard reports
Currency USD
$5,995

Can be used by individual purchaser only

Most Popular
$11,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$17,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more In Vitro Diagnostics reports
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Medical Devices
New
Traditional Wound Management Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | June 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at BRIC Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others in real time.

  • Access a live BRIC Oncology Market Outlook to 2033: Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more